{
    "2021-01-20": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Alzheimer's drug",
                        "stock surging",
                        "analyst"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Precision BioSciences' (DTIL) New Lymphoma Drug IND Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Precision BioSciences",
                        "lymphoma drug",
                        "FDA nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly signs cancer drug deal worth up to $1.6 billion",
                "features": {
                    "keywords": [
                        "Lilly",
                        "cancer drug",
                        "deal",
                        "$1.6 billion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",
                "features": {
                    "keywords": [
                        "FDA greenlights",
                        "Merck",
                        "heart failure drug",
                        "Histogen clinical hold",
                        "Aptorum human study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly (LLY) Inks Deal With Merus to Discover Cancer Antibodies",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Merus",
                        "cancer antibodies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}